These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 32345668)

  • 1. Co-occurrent Alterations of Alzheimer's Genes and Prostate Cancer Genes in Prostate Cancer.
    Lehrer S; Rheinstein PH
    Cancer Genomics Proteomics; 2020; 17(3):271-275. PubMed ID: 32345668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer Gene BIN1 may Simultaneously Influence Dementia Risk and Androgen Deprivation Therapy Dosage in Prostate Cancer.
    Lehrer S; Rheinstein PH
    Am J Clin Oncol; 2020 Oct; 43(10):685-689. PubMed ID: 32568785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoprotein.
    Geng C; Kaochar S; Li M; Rajapakshe K; Fiskus W; Dong J; Foley C; Dong B; Zhang L; Kwon OJ; Shah SS; Bolaki M; Xin L; Ittmann M; O'Malley BW; Coarfa C; Mitsiades N
    Oncogene; 2017 Aug; 36(33):4767-4777. PubMed ID: 28414305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Mechanistic Role of Bridging Integrator 1 (BIN1) in Alzheimer's Disease.
    Gao P; Ye L; Cheng H; Li H
    Cell Mol Neurobiol; 2021 Oct; 41(7):1431-1440. PubMed ID: 32719966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and genomic features of SPOP-mutant prostate cancer.
    Nakazawa M; Fang M; H Marshall C; Lotan TL; Isaacsson Velho P; Antonarakis ES
    Prostate; 2022 Feb; 82(2):260-268. PubMed ID: 34783071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT pathway.
    Luo Z; Wang J; Zhu Y; Sun X; He C; Cai M; Ma J; Wang Y; Han S
    Neoplasia; 2021 Oct; 23(10):1037-1047. PubMed ID: 34509929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinico-pathological significance of the molecular alterations of the SPOP gene in prostate cancer.
    García-Flores M; Casanova-Salas I; Rubio-Briones J; Calatrava A; Domínguez-Escrig J; Rubio L; Ramírez-Backhaus M; Fernández-Serra A; García-Casado Z; López-Guerrero JA
    Eur J Cancer; 2014 Nov; 50(17):2994-3002. PubMed ID: 25204806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity and tumor suppressor activity of Bin1 in prostate carcinoma.
    Ge K; Minhas F; Duhadaway J; Mao NC; Wilson D; Buccafusca R; Sakamuro D; Nelson P; Malkowicz SB; Tomaszewski J; Prendergast GC
    Int J Cancer; 2000 Apr; 86(2):155-61. PubMed ID: 10738240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BIN1 in the Pursuit of Ousting the Alzheimer's Reign: Impact on Amyloid and Tau Neuropathology.
    Kaur I; Behl T; Sundararajan G; Panneerselvam P; Vijayakumar AR; Senthilkumar GP; Venkatachalam T; Jaglan D; Yadav S; Anwer K; Fuloria NK; Sehgal A; Gulati M; Chigurupati S
    Neurotox Res; 2023 Dec; 41(6):698-707. PubMed ID: 37847429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of the SPOP mutant genomic subclass in prostate cancer.
    Shoag J; Liu D; Ma X; Oromendia C; Christos P; Ballman K; Angulo C; Cai PY; Gaffney C; Klein E; Karnes J; Den RB; Liu Y; Davicioni E; Barbieri CE
    Urol Oncol; 2020 May; 38(5):418-422. PubMed ID: 32192889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational and expressional analyses of SPOP, a candidate tumor suppressor gene, in prostate, gastric and colorectal cancers.
    Kim MS; Je EM; Oh JE; Yoo NJ; Lee SH
    APMIS; 2013 Jul; 121(7):626-33. PubMed ID: 23216165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BIN1 is decreased in sporadic but not familial Alzheimer's disease or in aging.
    Glennon EB; Whitehouse IJ; Miners JS; Kehoe PG; Love S; Kellett KA; Hooper NM
    PLoS One; 2013; 8(10):e78806. PubMed ID: 24205320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover.
    Geng C; He B; Xu L; Barbieri CE; Eedunuri VK; Chew SA; Zimmermann M; Bond R; Shou J; Li C; Blattner M; Lonard DM; Demichelis F; Coarfa C; Rubin MA; Zhou P; O'Malley BW; Mitsiades N
    Proc Natl Acad Sci U S A; 2013 Apr; 110(17):6997-7002. PubMed ID: 23559371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convergent lines of evidence support BIN1 as a risk gene of Alzheimer's disease.
    Zhu J; Liu X; Yin H; Gao Y; Yu H
    Hum Genomics; 2021 Jan; 15(1):9. PubMed ID: 33516273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHD1 and SPOP synergistically protect prostate epithelial cells from DNA damage.
    Zhu Y; Wen J; Huang G; Mittlesteadt J; Wen X; Lu X
    Prostate; 2021 Jan; 81(1):81-88. PubMed ID: 33022763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation in BIN1 gene and Alzheimer's disease risk in Han Chinese individuals.
    Tan MS; Yu JT; Jiang T; Zhu XC; Guan HS; Tan L
    Neurobiol Aging; 2014 Jul; 35(7):1781.e1-8. PubMed ID: 24582639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential contribution of the Alzheimer's disease risk locus BIN1 to episodic memory performance in cognitively normal Type 2 diabetes elderly.
    Greenbaum L; Ravona-Springer R; Lubitz I; Schmeidler J; Cooper I; Sano M; Silverman JM; Heymann A; Beeri MS
    Eur Neuropsychopharmacol; 2016 Apr; 26(4):787-95. PubMed ID: 26947052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TP53, SPOP and PIK3CA Genes Status in Prostate Cancer.
    Al Zoubi MS; Otoum R; Alorjani MS; Al Bashir S; Al Trad B; Abualrja MI; Al-Khatib SM; Al-Batayneh K
    Asian Pac J Cancer Prev; 2020 Nov; 21(11):3365-3371. PubMed ID: 33247697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations.
    Böttcher R; Kweldam CF; Livingstone J; Lalonde E; Yamaguchi TN; Huang V; Yousif F; Fraser M; Bristow RG; van der Kwast T; Boutros PC; Jenster G; van Leenders GJLH
    BMC Cancer; 2018 Jan; 18(1):8. PubMed ID: 29295717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPOP and FOXA1 mutations are associated with PSA recurrence in ERG wt tumors, and SPOP downregulation with ERG-rearranged prostate cancer.
    Hernández-Llodrà S; Segalés L; Safont A; Juanpere N; Lorenzo M; Fumadó L; Rodríguez-Vida A; Cecchini L; Bellmunt J; Lloreta-Trull J
    Prostate; 2019 Jul; 79(10):1156-1165. PubMed ID: 31090082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.